January 5, 2021

Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.

January 21, 2021

UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.

March 16, 2021

Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.

December 17, 2020

A recent study led by University of Cincinnati Cancer Center researchers shows the impact the pandemic had on lung cancer screening, which experts say could be bad for both screening programs in general and for the overall well-being of patients.

September 29, 2020

By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.

February 19, 2021

This week, more than 130 hospitals, research foundations, fundraising organizations and patient advocacy groups asked the Biden administration to put cancer patients first in the next stage of the rollout. The letter, which was signed by leaders at the UC Cancer Center, says research in the past year shows that COVID-19 patients with cancer have twice the death rate than those without cancer.

October 13, 2020

When Dr. Beth Shaughnessy, a UC professor and UC Health cancer surgeon, found out that she had cancer, she used it as an opportunity to share her path towards recovery and shed some light for others who might find themselves in the same situation.

April 14, 2023

University of Cincinnati Cancer Center researchers will present more than a dozen abstracts at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19, including findings that could advance treatments for head and neck and breast cancers.

April 12, 2022

The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.

June 6, 2022

The University of Cincinnati's Atsuo Sasaki and an international team of collaborators have been awarded a Human Frontier Science Program research grant to learn more about how cells migrate, with an ultimate goal of developing new treatments to prevent cancer growth and spread.